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Abstract
Toxin production in Clostridium perfringens is controlled by the VirSR two-component signal transduction system, which
comprises the VirS sensor histidine kinase and the VirR response regulator. Other studies have concentrated on the
elucidation of the genes controlled by this network; there is little information regarding the phosphorelay cascade that is
the hallmark of such regulatory systems. In this study, we have examined each step in this cascade, beginning with
autophosphorylation of VirS, followed by phosphotransfer from VirS to VirR. We also have studied the effects of gene
dosage and phosphorylation in vivo. We have used random and site-directed mutagenesis to identify residues in VirS that
are important for its function and have identified a region in the putative sensory domain of VirS that appeared to be
essential for function. In vitro phosphorylation studies showed that VirSc, a truncated VirS protein that lacked the N-terminal
sensory domain, was capable of autophosphorylation and could subsequently act as a phosphodonor for its cognate
response regulator, VirR. Conserved residues of both VirS and VirR, including the D57 residue of VirR, were shown to be
essential for this process. By use of Targetron technology, we were able to introduce a single copy of virR or virRD57N onto
the chromosome of a virR mutant of C. perfringens. The results showed that in vivo, when virR was present in single copy, the
production of wild-type levels of perfringolysin O was dependent on the presence of virS and an unaltered D57 residue in
VirR. These results provide good evidence that phosphorylation is critical for VirR function.
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Introduction
Clostridium perfringens is a Gram-positive, endospore-forming,
anaerobic pathogen that is the primary causative agent of gas
gangrene or clostridial myonecrosis, and other human and animal
diseases [1,2]. The production of the extracellular toxins, a-toxin
and perfringolysin O, which act synergistically in the gas gangrene
disease process [3,4,5,6], has been shown to be regulated by the
VirS sensor histidine kinase and its cognate response regulator,
VirR [1,7,8,9]. VirR is a transcription activator that directly
regulates the production of perfringolysin O, the cysteine protease
a-clostripain, and the regulatory RNA molecules, VR-RNA, VirT
and VirU [9,10,11,12,13]. It is through VR-RNA that the VirSR
system indirectly regulates the production of a-toxin, collagenase
(k-toxin) [9], b2-toxin [14], a putative collagen adhesin [14], a
cell-wall anchored DNase [15], and several housekeeping genes
[9,10,16,17].
The VirS sensor histidine kinase is predicted to contain six or
seven transmembrane domains in its N-terminal region. Its C-
terminal region contains several conserved motifs typical of
histidine kinases, including the proposed site of autophosphoryla-
tion, H255, and the G box, which is thought to be involved in
ATP binding [7,18]. It is postulated that upon detection of an as
yet unidentified signal by the N-terminal sensor region, VirS
autophosphorylates at H255 [7]. The phosphoryl group is then
transferred to a conserved aspartate residue, D57, that is located in
the N-terminal region of VirR. This region also contains the E8,
D9 and K105 residues, which in other response regulators are
highly conserved and form a phosphoacceptor pocket [19]. After
phosphorylation, activated VirR regulates the expression of its
target genes by binding to specific DNA binding sites [20] via its C-
terminal DNA binding domain [21]. We previously showed that
VirR activates transcription of the perfringolysin O structural
gene, pfoA, by binding independently to two imperfect 12-bp
directly repeated sequences, called VirR boxes, located upstream
of the pfoA promoter [20]. The maintenance of the integrity and
spatial organisation of these VirR boxes is crucial for optimal
perfringolysin O production [22]. In the three sequenced C.
perfringens genomes [12,23], VirR boxes have been identified
upstream of several other genes, including genes encoding VR-
RNA and a-clostripain. We have shown that these VirR boxes are
functional and that VirR recognises and binds to each of these
alternative binding sites [12,22].
Although the role of the VirSR system in toxin production has
been established, the N-terminal region(s) required for VirS
function have not been determined and the role of phosphoryla-
tion in transcriptional activation has not been demonstrated. In
this paper we identify a region located within one of the putative
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function and show, using in vitro phosphorylation studies, that a
truncated form of VirS is able to undergo autophosphorylation
and subsequently act as the phosphodonor for VirR. Using
perfringolysin O production as a reporter system for VirR
function, we showed that activation of transcription was
dependent on the presence of VirS and the D57 residue of VirR.
These studies demonstrated that phosphotransfer from VirS to
VirR and gene dosage were important factors in the regulation of
perfringolysin O production by VirR.
Materials and Methods
Bacterial strains, plasmids and growth conditions
Bacterial strains are listed in Table 1, while plasmids are listed in
Table S1. Escherichia coli strains were grown at 37uCi n2 6YT or
SOC media [24] supplemented with either 100 mgm l
21 ampicil-
lin or 30 mgm l
21 chloramphenicol. C. perfringens strains were
grown at 37uC in fluid thioglycollate medium (FTG) (Difco),
trypticase-peptone-glucose (TPG) broth [25], Brain Heart Infusion
(BHI) broth (Oxoid) or nutrient agar (NA) [26]. Where indicated,
NA supplemented with 50 mgm l
21 erythromycin (NAEm50)o r
30 mgm l
21 chloramphenicol (NACm30) was used for selection
purposes. To screen for phospholipase C production, C. perfringens
transformants were grown on egg yolk agar [27] supplemented
with 30 mgm l
21 chloramphenicol (EYACm30), whilst perfringo-
lysin O activity was visualised on horse blood agar (HBA) [7]. All
C. perfringens agar cultures were incubated under anaerobic
conditions in 10% (v/v) H2, 10% (v/v) CO2 in N2.
Perfringolysin O assay
The level of perfringolysin O activity in the culture supernatants
was determined by a doubling dilution hemolysin assay using
horse red blood cells, as previously described [3]. The titre was
defined as the reciprocal of the last well that showed complete
hemolysis.
Molecular techniques
Plasmid DNA was isolated from E. coli [28] and C. perfringens
[29] cells as previously described. DNA for sequencing was
prepared as per the PRISM Big Dye Terminator Cycle
Sequencing Ready Reaction Kit (Applied Biosystems). Restriction
endonucleases and other enzymes were used as specified by the
manufacturer (Roche Diagnostics, New England Biolabs). All
oligonucleotide primers are listed in Table S2
Competent E. coli [30] and C. perfringens [31] cells were prepared
and transformed as described previously, unless otherwise
indicated. C. perfringens genomic DNA was isolated from 5 ml
FTG broth cultures as before [32]. PCR amplification was carried
out as before [22]. PCR products were purified either directly
using QIAquickH PCR Purification Kit (Qiagen) or were extracted
from agarose gels using the QIAquickH Gel Extraction Kit
(Qiagen), according to the manufacturer’s instructions.
Random Mutagenesis
Random virS mutants were isolated after passage through the
DNA repair deficient strain Epicurean ColiH XL1-Red (Strata-
gene). The target plasmid was pJIR884 [7], which contains an
intact copy of the virS gene and the upstream virR promoter. Four
independently derived pJIR884 DNA samples were obtained from
transformed XL1-Red cells and used to transform C. perfringens
strain JIR4000, a JIR325 derivative in which the virS gene has
been insertionally inactivated by Tn916 [7]. To isolate random
mutations by chemical mutagenesis, pJIR884 was incubated in
1 M hydroxylamine in 1 mM EDTA (pH 6) for 30 to 180 min at
70uC. Plasmid DNA was then used to transform strain JIR4000.
Irrespective of the mutagenesis method, virS mutants were detected
as non-hemolytic colonies on HBA supplemented with
50 mgm l
21 erythromycin. Since perfringolysin O production is
dependent upon the VirSR system [22,33], an inability to
complement the virS mutation in JIR4000, i.e. no hemolysis on
HBA, was used as a direct means of detecting loss of VirS function.
To facilitate analysis, plasmid DNA was recovered from all non-
hemolytic strains of C. perfringens and used to transform E. coli.
Sequence analysis was carried out on DNA isolated from the
resultant E. coli strains to identify plasmids with mutations within
the virS gene. Sequence analysis was used to identify plasmids with
mutations within the virS gene. Selected plasmids derived from
both methods of random mutagenesis were further analysed and
are listed in Table 2.
Site-directed Mutagenesis
Site-directed mutagenesis of the virS gene carried on pJIR2056
was performed using a modification of the unique site elimination




DH5a F-w80D lacZdM15D(lacZYA-argF)U169 endA1recA1 hsdr17(tk
2mk
+)deoR thi-1 supE44 gyrA96 relA1 Bethesda Research Laboratories
BL21(DE3) (C43) F’ompT hsdSB(rB‘‘mB’’) gal dcm (DE3) (C43) [35]
Epicurian ColiH XL1-Red endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac mutD5 mutS mutT Tn10(Tet
r ) Stratagene
C. perfringens
TS133 Strain 13 virR :: Tc
R [8]
JIR325 Strain 13 Nal
R Rif
R [7]
JIR4000 JIR4025 virS::Tn916 [7]
JIR12100 TS133 plc :: Targetron This study
JIR12106 TS133 plc :: TargetronVvirRD57N This study
JIR12136 TS133 plc :: TargetronVvirR This study
doi:10.1371/journal.pone.0005849.t001
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TM (Amersham
Pharmacia Biotech), the GeneEditor
TM in vitro Site-Directed
Mutagenesis Kit (Promega) [21], or the PCR-based Quikchange
TM
XL Site-Directed Mutagenesis Kit (Stratagene). The virS genes and
upstream promoter regions of the mutated plasmids were sequenced
to confirm that only the desired mutation was present. To test the
effectofthe mutations on VirSfunction,a 3.8-kb XbaI/SalIf r a g m e n t
from each mutated plasmid was isolated, cloned into the XbaI/SalI
site of the E. coli/C. perfringens shuttle vector pJIR751, and used to
transform C. perfringens strain JIR4000. Site-directed mutagenesis of
the virR gene and the cloning of the resultant mutated genes were
carried out as described previously [21].
Construction of expression plasmids
To overexpress VirSc and its derivatives, VirScH255I and
VirScG402D, a 0.69 kb PCR product was generated using the
primers JRP1873 and JRP1133 (Table S2). These primers
incorporated NdeI and XhoI sites at the 59 and 39 ends, respectively,
which facilitated the insertion of the DNA fragment into the
expression vector pET-22b(+) (Novagen) to construct pJIR2699,
pJIR2792 and pJIR2825, respectively (Table S1). To overexpress
N-terminal 66His tagged VirRD57N, a 0.9 kb XbaI/HindIII
fragment from pJIR1732 (Table S1) was subcloned into pRSETA
(Invitrogen) to produce pJIR1747.
Overexpression and purification of His-tagged proteins
To induce the expression of recombinant proteins, E. coli C43
(DE3) [35] derivatives were induced with 1 mM IPTG for 3 h at
37uC (VirSc,VirScH255I & VirScG402D)o r1ha t3 7 uC (VirR &
VirRD57N). Proteins were purified using Talon resin (Clonetech)
and dialysed as described previously [33]. Protein concentration
was determined with the bicinchoninic acid protein assay kit
(Pierce).
Autophosphorylation of VirSc and Phosphotransfer from
VirSc to VirR
VirSc was diluted in phosphorylation buffer (50 mM HEPES
[pH 8.0], 50 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 2 mM
DTT) to a final concentration of 20 mM, and aliquoted for use in
individual phosphorylation reactions. Phosphorylation was initiat-
ed by the addition of 0.1 volumes of a 106 reaction mixture
containing either 2.5 mM[ c-
32P]ATP (111TBq/millimole) (Perkin
Elmer Life Sciences) and 247.5 mM unlabelled ATP, or 247.5 mM
unlabelled ATP alone. The latter reaction mixture was added to
unlabelled reactions that were subject to Western blot analysis
using a Penta-His antibody (Qiagen). To examine autopho-
sphorylation specificity, reactions were pre-incubated with 50 mM
EDTA or 2.5 mM unlabelled ATP at room temperature (approx
23uC) for 5 min before the addition of the 106reaction mixture.
Table 2. The effect of virS mutations on perfringolysin O production.
Strain Base Change
b/Characteristic Amino Acid Change PFO titre (log)2
a
Random Mutants
JIR4000(pJIR751) vector control ,1
JIR4000(pJIR884) virS
+ positive control 5.860.1
JIR4000(pJIR2108)* CTT R TTT L99F ,1
JIR4000(pJIR1983) ACA R GCA T100A ,1
JIR4000(pJIR2105)* GAA R AAA E102K ,1
JIR4000(pJIR1977) CAT R TAT H255Y ,1
JIR4000(pJIR1930) GAT R GGT D256G ,1
JIR4000(pJIR2028) AAT R AAA N259K ,1
JIR4000(pJIR2106)* CAC R TAC H260Y ,1
JIR4000(pJIR2073) TGT R TAT C335Y ,1
JIR4000(pJIR1953) GGC R GAC G402D ,1
JIR4000(pJIR2186)* GGA R AGA G415R ,1
Site-Directed Mutants
JIR4000(pJIR2306) ATT R TTT I88F 4.660.1
JIR4000(pJIR2305) TTA R TTT L92F 3.760.1
JIR4000(pJIR2326) TTA R GCA L96A 5.760.1
JIR4000(pJIR2325) TTA R AAT L96N 5.760.1
JIR4000(pJIR2206) TTA R TTT L96F ,1
JIR4000(pJIR2379) CTT R AAT L99N ,1
JIR4000(pJIR2378) CTT R GCA L99A ,1
JIR4000(pJIR2175) ACA R TCA T100S 5.060.5
JIR4000(pJIR2173) ACA R TGT T100C 2.060.4
JIR4000(pJIR2177) ACA R GTA T100V ,1
JIR4000(pJIR2231) CTA R TTT L104F 4.660.3
aPFO titre6SD: Perfringolysin O activity is shown as the average of duplicate assays carried out on preparations from at least three separate cultures of each strain.
bBase changes are shown in bold.
*refers to hydroxylamine derived mutants.
doi:10.1371/journal.pone.0005849.t002
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stopped by the addition of an equal volume of 26 gel loading
buffer, and then subjected to SDS-PAGE [36]. The labelled gel
was then vacuum dried and exposed to X-ray film (Fuji).
For phosphotransfer studies, VirSc (10 mM) was autopho-
sphorylated as above, in a total volume of 10 ml, with the
exception that reactions were carried out in phosphotransfer buffer
(50 mM MOPS [pH 7.0], 50 mM KCl, 10 mM MgCl2, 0.5 mM
EDTA, 2 mM DTT) and incubated at room temperature for 1 h.
VirR or VirRD57N was then added to a final concentration of
0.9 mM, and reactions were incubated for a further 15 min at
room temperature before the addition of 106 reaction mixture
and incubation at room temperature for varying amounts of time.
Proteins were separated by SDS-PAGE and gels were treated as
before. The presence of proteins in these phosphorylation studies
was verified by Western blot analysis using His-tag antibodies on
duplicate reaction samples (data not shown).
Isolation of C. perfringens cell extracts
Cell pellets derived from 1 ml TPG broth cultures were
resuspended in 350 mlo f1 6PBS, approximately 100 ml of 150–
212 micron glass beads (Sigma-Aldrich) was added and the cells
were lysed by vigorous agitation, twice for 45 sec, in a FastPrep
FP120 Cell Disrupter (Savant/Bio101). Cell debris was removed
by centrifugation at 12,000 g for 10 min at 4uC, and the soluble
whole cell extracts were collected. Following determination of the
protein concentration, 20 mg of each extract was used in Western
blot analysis with VirR-specific antisera.
Western blot analysis
Following SDS-PAGE, proteins were transferred to Protran
nitrocellulose membrane (Schleicher and Schuell) using a mini
Trans-BlotH Electrophoretic Transfer Cell (BioRad) for Western
blot analysis. The nitrocellulose membrane was developed using
Penta-His antibody (1:2000 dilution) or VirR-specific antiserum
(1:1000 dilution) [21] and the Western Lightning Chemilumines-
cence Reagent (Perkin Elmer Life Sciences), in accordance with
the manufacturer’s instructions.
Introduction of virR and virRD57N onto the chromosome
by use of a Targetron
To construct the plasmids used to introduce virR and virRD57N
onto the chromosome, the genes were PCR amplified using
primers JRP2812 and JRP2813 (Table S2). The oligonucleotides
introduced MluI sites that facilitated cloning into the unique MluI
site within the plc target region of pJIR750ai [37], such that the
genes were transcribed in the same direction as the intron. The
resultant plasmids, pJIR3326 (virR) and pJIR3243 (virRD57N) were
introduced into C. perfringens strain TS133 (Table 1) by
electroporation as before [38]. Transformants were selected on
NACm30 and several transformants were subcultured into FTG
broth. After overnight incubation at 37uC, 1 ml of each culture
was used to inoculate 20 ml of BHI broth and grown at 37uC for
4 h. Cultures were then serially diluted and subcultured onto
EYACm30. After overnight incubation at 37uC, colonies that were
not surrounded by a white zone of opalescence were selected for
further analysis. These colonies represented cells in which the a-
toxin gene, plc, had been disrupted by the Targetron. The
insertion of the element was confirmed by PCR, using primers
JRP2873 and JRP2874 (Table S2). To cure the strains of the
replicating plasmid constructs, the strains were passaged twice a
day in 20 ml of BHI broth for five days. Single colonies were
isolated and those that were chloramphenicol sensitive were
selected for further analysis. Southern blots were carried out as
previously described [37] using DIG-labelled catP, virR and plc
probes to confirm the insertion of the genes on the chromosome
and the loss of the Targetron plasmid constructs (data not shown).
Isolation of RNA and Quantitative Real Time (QRT)-PCR
C. perfringens total RNA was isolated as described previously [18]
and 2 mg of RNA converted to cDNA using AMV reverse
transcriptase (Promega) in accordance with the manufacturer’s
instructions. The reaction products were diluted fivefold before use
in QRT-PCR experiments, as described previously [32]. The
QRT-PCR reactions were carried out on an ABI PRISM 7700
sequence detector, in a final volume of 25 ml with SYBR Green
PCR master mix (Applied Biosystems), 2 ml of diluted RT reaction
as the template and 120 nM of each primer (Table S2). To
determine gene copy number, 0.2 ng of genomic DNA was used as
the template. Total RNA or genomic DNA of each strain was
isolated from three biological replicates, and each sample was
assayed in triplicate. The values obtained were normalised to that
of the rpoA gene for each strain, and the results expressed as a
proportion of the wild-type.
Results
Identification of functional residues in VirS
VirS contains several residues and motifs that are conserved in
C-terminal domains of sensor histidine kinases, including the
putative site of autophosphorylation, H255, and the G (GxGL)
motif (Fig. 1). In previous work, six or seven transmembrane
regions were predicted in the N-terminal region of VirS. In this
study, a new model of VirS was obtained using three independent
transmembrane prediction algorithms: TMHMM (http://www.
cbs.dtu.dk/services/TMHMM/), Phobius (http://phobius.cbr.su.
se/) and Sosui (http://bp.nuap.nagoya-u.ac.jp/sosui/). These
algorithms showed a consensus topology, where the extracellular
N-terminus was followed by seven transmembrane domains, and
the catalytic C-terminal region was cytoplasmically located (Fig. 1).
Attempts at verifying this topology using PhoA/LacZ fusions were
unsuccessful (data not shown).
With this model in mind, random mutagenesis was used to
identify VirS residues of functional importance, particularly within
the N-terminal domain. Mutagenesis of the virS
+ shuttle plasmid
pJIR884 [7] led to the isolation of 134 non-hemolytic mutants,
each containing plasmids that were indistinguishable from
pJIR884 by restriction analysis. Eighteen of these plasmids were
found to contain a single point mutation in the virS structural gene,
10 of which were unique (Fig. 1) and therefore were subjected to
quantitative analysis. None of these mutants conferred any
detectable perfringolysin O activity (Table 2), indicating that the
mutations had eliminated all measurable VirS function. RT-PCR
was used to confirm that the mutated virS genes were still
transcribed in C. perfringens (data not shown).
Three of the VirS substitutions, L99F, T100A and E102K, were
located in the N-terminal region, within a putative transmembrane
domain (TMD 4). The other changes were all located within the
cytoplasmic C-terminal domain. Four substitutions, H255Y,
D256G, N259K and H260Y, were located either in or near
H255, the putative site of autophosphorylation. One alteration,
C335Y, was close to the conserved N box, a region predicted to
form part of the catalytic domain that binds ATP. The G402D
and G415R substitutions were located in or near the G box, which
is also predicted to form part of the catalytic domain [39].
To define the functional region in this N-terminal portion of
VirS, several leucine residues on either side of L99, and upstream
VirSR Phosphotransfer
PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e5849of E102, were targeted for substitution. The sequence of this
leucine rich region is 88IMISLIFWLFMLTVEAL104. The leucine
residues adjacent to L99, L104 and L96, were altered to
phenylalanine, on the basis that the random L99F mutation
eliminated VirS function. The L104F substitution had no
significant effect on perfringolysin O production (Table 2),
suggesting that this residue is not essential for VirS function. By
contrast, the L96F mutation had a dramatic effect on VirS
function, eliminating VirS activity. Further mutagenesis of L96 to
alanine or asparagine, had no significant effect on perfringolysin O
activity, suggesting that the size of the side-chain was the critical
factor at this position. To further delineate this putative motif, L92
and I88 were also altered to phenylalanine. These changes had
little effect on perfringolysin O activity (Table 2), implying that
these residues were not of functional significance.
The amino acid requirements at positions 99 and 100 were also
determined by site-directed mutagenesis, the requirement for a
glutamate residue at position 102 having been determined
previously [18]. The substituted amino acids were chosen so that
they had an altered size or charge compared to the original residue
in that position. Alteration of L99 to either alanine or asparagine
abolished VirS function (Table 2), implying that both the length
and hydrophobicity of the side-chain at this position was
important. At position 100 a hydroxyl group was required since
T100V was inactive, T100C was partially functional and T100S (a
conservative substitution) had almost wild-type activity. Based on
these data we have designated this region of VirS as the L[T/
S]6E motif, and postulate that due to its location it is either
required for the conformational change that induces autopho-
sphorylation, or for the structural integrity of VirS.
Residues in the C-terminal domain of VirS are essential
for autophosphorylation
The next step in our systematic analysis of the VirSR
phosphorelay was to determine whether VirS was able to undergo
autophosphorylation. The VirS protein is postulated to contain
multiple transmembrane domains in the N-terminal region, with
the catalytic motifs being localised in the cytoplasmic C-terminal
domain [7,18]. Since attempts to purify full-length VirS were
unsuccessful, a virS segment encoding the C-terminal domain
(amino acids 215 to 440) was cloned into the pET-22b(+)
expression vector, and a 27.7 kDa 66-His tagged protein (VirSc)
overexpressed. After purification on a Talon column, VirSc was
used in autophosphorylation experiments using [c2
32P]ATP or
[a-
32P]ATP. A single band corresponding to the correct size of
VirSc (27.7 kDa) was observed in the [c2
32P]ATP reaction
(Fig. 2A, lane 3), indicating that VirSc was able to undergo
autophosphorylation. Moreover, labelling of the protein occurred
through the specific transfer of the c-phosphoryl group from ATP
to VirSc, since the protein could be labelled with [c2
32P]ATP,
but not with [a-
32P]ATP (Fig. 2A, lane 4), indicating that labelling
occurred through a specific phosphotransfer process. The
autophosphorylation reaction was found to require divalent metal
ions, since pre-incubation of VirSc with 50 mM EDTA inhibited
Figure 1. Model of the VirS sensor histidine kinase. The predicted topology of VirS consists of an extracellular N-terminus, seven
transmembrane domains (blue rectangles) and a cytoplasmic C-terminal region. The amino acids encompassing the transmembrane domains as
predicted by the TMHMM, Phobius and Sosui algorithms are shown beside the predicted loop regions and are written in black, red and green,
respectively. The consensus [39] H box (Fhxxh(S/T/A)H(D/E)h(R/K)TPLxxh), N box ((D/N)xxxhxxhhxNLhxNAh.(F/H/Y)(S/T)) and G box
(GGxGLGLxhhxxhhxxxxGxhxhxxxxxxGxxFxhxh) are represented by the yellow squares, while the positions of the random mutations are as indicated.
doi:10.1371/journal.pone.0005849.g001
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molar excess of unlabelled ATP competitor also abrogated
autophosphorylation (Fig. 2A, lane 6).
In a previous study, mutation of the conserved histidine residue
(H255I), or the first glycine residue in the conserved G box
(G400A), was shown to eliminate VirS function [18]. Similarly, the
C335Y and G402D substitutions of VirS, which were identified
through random mutagenesis in this study, also eliminated VirS
function (Table 2). To examine what effects these changes had on
autophosphorylation in vitro, VirSc proteins containing these
modifications were purified and tested for their ability to
autophosphorylate. The results showed that a phosphorylated
protein band was not observed with VirScH255I (Fig. 2B, lane 2),
indicating that this derivative was no longer able to carry out
autophosphorylation and that this histidine residue was involved in
this reaction. Analysis of the VirScC335Y derivative showed that
this mutation also eliminated the ability of the protein to
autophosphorylate (Fig. 2B, lane 3). Therefore, although C335 is
located near to, but is not part of the actual N box, it still plays an
important structural or functional role in the VirS autopho-
sphorylation process. Significantly reduced VirS-specific autopho-
sphorylation was detected with VirScG400A (Fig. 2B, lane 4),
implying that although the first glycine residue in the G box is
important for the autophosphorylation of VirS, very low level
phosphorylation is possible when it is altered. However, alteration
of the second glycine residue in this motif (G402D) completely
eliminated autophosphorylation (Fig. 2B, lane 5). Taken together,
these results provided experimental evidence that the motifs and
residues predicted to be essential for ATP binding and kinase
activity are required for autophosphorylation.
Phosphotransfer from VirSc to VirR in vitro
Using phosphorylated VirSc (VirSc-P) as the phosphodonor, we
then tested the ability of purified VirR to act as a phosphoaccep-
tor. The appearance of a labelled band corresponding to VirR was
observed (Fig. 3A). This result provided evidence for the transfer of
the phosphoryl group from VirSc-P to VirR, indicating that VirR
was able to interact with the truncated VirS protein. A
phosphorylated response regulator band was not observed when
purified VirR containing a substitution at the putative D57
phosphoacceptor site (VirRD57N) was tested under the same
conditions (Fig. 3B). Furthermore, the intensity of this VirSc-P
band did not appear to diminish over time. It was concluded that
the VirRD57N was not able to be phosphorylated and that D57 was
most likely the site of phosphorylation in VirR.
VirR proteins with mutations in conserved residues are
still functional in vivo
To determine whether the VirRD57N protein was functional in
vivo, the virRD57N gene was subcloned into the E. coli-C. perfringens
shuttle vector, pJIR750 [40], and the resultant plasmid, pJIR1882,
was introduced into C. perfringens virR mutant TS133 [8] (Table 1).
Since complementation of the virR mutation in TS133 with a
plasmid carrying a wild-type virR gene results in the restoration of
perfringolysin O activity [8], perfringolysin O production was used
to determine the effect of the mutations. Unexpectedly, when the
shuttle plasmid carrying the virRD57N gene was introduced into
TS133, the resultant strain carrying the mutated gene produced
less perfringolysin O than the wild-type, but still produced very
significant levels of the toxin (Table 3).
Another derivative was subsequently constructed in which the
putative essential lysine residue [7] was substituted (K105E). When
this mutated virR gene was introduced into TS133, similar results
were obtained (Table 3). Finally, in case alternate acidic residues in
the phosphoacceptor site were being used as phosphoacceptors, a
mutant was constructed in which D57 and the other residues in
the acceptor pocket, E8 and D9, were substituted. This virRE8N D9N
D57N mutation, referred to as virRNNN, was also capable of fully
complementing the virR mutation in TS133 (Table 3). Confirma-
tion that all the plasmids analysed in this strain had retained the
expected mutations and had not undergone further virR changes
was obtained after plasmid extraction and sequence analysis.
The gene dosage of virR is important for the normal
regulation of perfringolysin O production
We postulated that this apparent phosphorylation independence
occurred as a result of gene dosage effects. To test this hypothesis,
we utilised an a-toxin (plc)-targeted Targetron vector [37] as a
novel means of introducing virR genes back onto the chromosome
in single copy. Using this method we constructed separate strains
in which the wild-type virR gene or the virRD57N gene was inserted
Figure 2. Autophosphorylation of VirSc and its derivatives. (A)
In the absence of purified VirSc, a labelled protein band was not
observed in the presence of [c-
32P]ATP (lane 1) or [a-
32P]ATP (lane 2). A
labelled band of ,27 kDa was observed when purified VirSc (20 mM)
was incubated in phosphorylation buffer in the presence of [c-
32P]ATP
(lane 3). To show specificity of autophosphorylation, VirSc was
incubated with [a-
32P]ATP (lane 4), or with [c-
32P]ATP in the presence
of 50 mM EDTA (lane 5) or 2.5 mM unlabelled ATP (lane 6). (B)
Autophosphorylation of substituted derivatives of VirSc. VirSc was able
to autophosphorylate (lane 1), while VirScH255I (lane 2), VirScC335Y (lane
3) and VirScG402D (lane 5) could not undergo autophosphorylation.
VirScG400A (lane 4) showed severely reduced autophosphorylation. The
band corresponding to phosphorylated VirSc (,27 kDa) is indicated by
the arrow. Molecular size markers (kDa) are as indicated.
doi:10.1371/journal.pone.0005849.g002
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operon, the original insertional inactivation of virR in TS133 also
eliminated the expression of virS [41]. Therefore, to reconstitute
the VirSR regulatory system, pJIR884, which carries the wild-type
virS gene [7], was introduced into each of these strains to provide
virS in trans. Control strains carried the vector plasmid pJIR751.
QRT-PCR using genomic DNA showed that as in the wild-type
strain there was one copy of virR or virRD57N in the Targetron-
derived chromosomal plc insertion derivatives although there were
an average of 15 copies of virR and 18 copies of virRD57N in the
TS133 strains carrying these genes on plasmids. As an internal
control, the copy number of the pfoA gene was determined to be
one in all of these strains, as expected (Fig. 4A).
Perfringolysin O assays were carried out to determine the
phenotypic effect of these different virR gene doses. Expression of
both the virR and virRD57N genes on multicopy plasmids in TS133
(strains JIR4508 and JIR4487, respectively) resulted in wild-type
levels of perfringolysin O activity (Table 3), despite the absence of
virS in these strains. By use of QRT-PCR analysis, the expression
levels of the virR genes in these strains were shown to be
significantly higher than in the wild-type strain (Fig. 4B). In
addition, Western blotting using VirR-specific antiserum showed
that there were higher levels of VirR protein in these cells (Fig. 4C).
These results indicated that when VirR or VirRD57N was present
in the cell at higher concentrations, the response regulator no
longer needed to be activated by phosphorylation to be functional.
This observation is clearly illustrated by the results with VirRD57N,
which was not able to be phosphorylated in vitro, but was still able
to stimulate high levels of perfringolysin O production when
encoded on a multicopy plasmid. By contrast, when the virRD57N
Figure 3. Phosphotransfer from VirSc to VirR. VirSc (10 mM) was incubated in phosphotransfer buffer in the presence of [c-
32P]ATP at room
temperature before purified (A) VirR or (B) VirRD57N was added. Reactions were incubated at room temperature for the time indicated above each
well. The first lane of each gel contains autophosphorylated VirSc, while subsequent lanes show the reactions with both phosphorylated VirSc and
VirR or VirRD57N. The band corresponding to phosphorylated VirSc (,27 kDa) or VirR (,32 kDa) is indicated by the arrow or an asterisk, respectively.
Molecular size markers (kDa) are as indicated.
doi:10.1371/journal.pone.0005849.g003
Table 3. Effect of virR genes on perfringolysin O production.
Strain Characteristics PFO Titre* (log2)
JIR325 Wild-type 7.860.4











+ (NNN ) 7.960.3
JIR12142 TS133(pJIR884), virS
+ ,1.0
JIR12146 TS133 plc :: Targetron(pJIR884), plc virS
+ ,1.0
JIR12157 TS133 plc :: TargetronVvirR(pJIR751), plc virR
+ 4.060.7
JIR12154 TS133 plc :: TargetronVvirR(pJIR884), plc virR
+ virS
+ 7.860.1
JIR12152 TS133 plc :: TargetronVvirRD57N (pJIR751), plc virRD57N
+ ,1.0
JIR12150 TS133 plc :: TargetronVvirRD57N (pJIR884), plc virRD57N
+ virS
+ ,1.0
*PFO titre6SD: Perfringolysin O activity is shown as the average of duplicate assays carried out on preparations from at least three separate cultures of each strain.
aStudent’s t-test P,0.01, when compared to JIR4508.
bStudent’s t-test P,0.05, when compared to JIR4508.
doi:10.1371/journal.pone.0005849.t003
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PLoS ONE | www.plosone.org 7 June 2009 | Volume 4 | Issue 6 | e5849Figure 4. Determination of virR copy number, virR expression levels and VirR levels in C. perfringens. (A) Determination of virR copy
number. Genomic DNA from each strain was isolated from three biological replicates and assayed in triplicate by QRT-PCR. The gene copy number of
virR (black bars) and pfoA (white bars) in each strain relative to the wild-type (WT) copy number normalised to the rpoA gene is shown. The strains are
indicated below each set of bars, and the chromosomal (c) or plasmid (p) location of the virR, virRD57N and/or virS genes is shown beneath each strain.
(B) Determination of virR expression using QRT-PCR. Total RNA from each strain was isolated from three biological replicates and assayed in triplicate.
The expression levels of virR (black bars) in each strain relative to WT levels normalised to the rpoA gene (relative gene expression) are shown. The
strains are indicated as for (A). In (A) and (B), the error bars represent the standard error of the mean, and the asterisks (*) represent a P-value of,0.05
calculated by two-tailed Student’s t-test. (C) Immunoblot analysis of wild-type and TS133 derivatives. Western blots were carried out on whole cell
extracts of the strains indicated above each lane. A brief description of each strain is given below the blot. The blots were probed with polyclonal
rabbit VirR antiserum, followed by chemiluminescent detection. Molecular size markers (kDa) are as indicated.
doi:10.1371/journal.pone.0005849.g004
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confirmed by genomic QRT-PCR analysis, the resultant strain
was not able to produce perfringolysin O (Table 3). The
expression levels of the single copy genes, including the wild-type
strain, were significantly lower than the genes carried on the
multicopy plasmids (Fig. 4B), and the respective protein concen-
trations were so low that they were not detected by the VirR-
specific antisera in Western blots (Fig. 4C). These results suggest
that the virR gene dosage is an important factor in the regulation of
perfringolysin O production.
Analysis of chromosomal mutants reveals that
phosphorylation of VirR is essential for optimal
perfringolysin O production
The chromosomal derivatives were also used to assess the effect
of the presence of virS, that is, the effect of phosphotransfer, on
perfringolysin O production (Table 3). The results showed that
despite the presence of a plasmid carrying the wild-type virS gene,
no perfringolysin O activity could be detected in the virR mutant
TS133, indicating that, as expected, overexpression of virS alone
could not activate perfringolysin O production. By contrast,
perfringolysin O activity was restored to wild-type levels when the
virS plasmid, pJIR884, was introduced into TS133 complemented
with the chromosomal virR gene. These results provided in vivo
evidence that VirS, in the presence of VirR, is required to activate
the expression of pfoA and were consistent with the in vitro
phosphorylation data. Analysis of the data obtained with the
chromosomal virRD57N showed that no detectable perfringolysin O
activity was observed even when virS was present. It was concluded
that D57 was an essential residue for VirS-dependent VirR
function in vivo.
QRT-PCR using total RNA was carried out to determine
whether these results were due to variation in virR or virRD57N
expression levels. In each of the chromosomal complementation
derivatives the relevant virR gene was expressed at levels similar to
the wild-type (Fig. 4B). Therefore, even though the virRD57N gene
was being expressed at levels similar to wild-type virR, the resultant
protein was not able to activate the production of perfringolysin O.
Furthermore, the presence of a functional virS gene in multicopy
did not increase the expression of the virR genes (Fig. 4B), nor the
amount of VirR protein (Fig. 4C). These results suggest that the
higher perfringolysin O activity in the chromosomal virR
complementation derivative was a result of VirS modifying the
VirR protein, a process that requires the D57 residue of VirR.
Taken together the results provide evidence that in vivo
phosphorylation is crucial for optimal perfringolysin O produc-
tion.
Discussion
Although the VirSR two-component regulatory system is well
studied [1,13,20], very little is known about the actual phosphor-
elay cascade. It has always been postulated, but never experimen-
tally demonstrated, that activation of the VirSR system begins with
the interaction of an unknown signal molecule with VirS and
subsequent VirS autophosphorylation. In this study, we have
identified an essential N-terminal VirS motif, L[T/S]6E, that may
be involved in the activation of VirS after detection of the
unknown signal molecule. Further studies would be required to
test this hypothesis, once the signalling molecule has been
identified. Early studies on toxin production [42,43,44] have led
to the hypothesis that the VirSR system may potentially be
activated by a quorum sensing mechanism involving a secreted
molecule called substance A [1,20]. Although, this elusive
molecule has yet to be isolated, recent studies have suggested that
it is a cyclic derivative of the quorum sensing peptide
(TSACLWFT), which is the secreted product of the agrBD
CP
genes [45].
Alternatively, the L[T/S]6E region may play an important role
in transmembrane helix packing. Residues such as glutamate,
serine and threonine have been found to be crucial in the tight
helical packing of membrane bound proteins, which in turn
contributes to the stability, folding and subsequently, the function
of the protein [46]. Therefore, the introduced changes may have
caused a disruption in protein structure, leading to either
misfolding or instability of VirS. At present, however, reliable
VirS antisera is not available to examine whether protein stability
is affected by the mutations. Nevertheless, the observation that not
all the residues surrounding the L[T/S]6E motif were required
for VirS function implies that the residues in this motif are of
functional significance. We have also shown that a truncated VirS
protein, VirSc, is able to autophosphorylate, in the absence of the
N-terminal sensory domain. Autophosphorylation requires diva-
lent cations and is ATP-dependent, with the c-phosphoryl moiety
of ATP being transferred to VirSc. Furthermore, we have shown
that the conserved C-terminal motifs postulated to be required for
autophosphorylation are indeed functional.
The conserved histidine residue in sensor kinases is the site of
autophosphorylation [19,47], where it is suggested to function as
the nucleophile that attacks the ATP c-phosphate [48,49]. In this
study, it was shown that a VirScH255I protein could not be
phosphorylated in vitro, which was consistent with the in vivo results
obtained previously [18], where a virSH255I gene was not able to
complement a chromosomal virS mutation. Taken together these
results provide good evidence that H255 is essential for VirS
function. Although H255 has been postulated to be the site of
autophosphorylation, the finding that another histidine residue,
H260, also affected protein function suggests that either histidine
could potentially act as the site of phosphorylation. However,
determination of the actual site was beyond the scope of this study.
The glycine residues of the G box were also found to be important.
In particular, the second glycine, G402, was shown to be essential,
since mutation of this residue resulted in elimination of autopho-
sphorylation. A non-functional virScC335Y mutant was isolated in
the random mutagenesis experiments and the resultant VirScC335Y
protein was not labelled in the presence of [c-
32P]ATP, suggesting
that C335 is required for autophosphorylation. The C335Y
substitution was located about 10 amino acids N-terminal to the
proposed N box, which in other systems is important in ATP
binding and hence, autophosphorylation [50,51,52]. Residues
located outside of the conserved motifs have been found to be
involved in interactions with the bound nucleotide [53].
Therefore, it is possible that although C335 is not part of the N-
box, it may associate with the bound ATP molecule. Alternatively,
the effect of the cysteine to tyrosine change could be structural.
Note that it was not possible to test the effect of the substitutions in
the L[T/S]6E motif on autophosphorylation because we were
unable to purify full-length VirS and the truncated VirSc protein
did not include these residues.
The C-terminal region also appears to be capable of protein-
protein interactions with the cognate response regulator, VirR,
since phosphotransfer from phosphorylated VirSc to VirR was
observed. This result represents the first time phosphotransfer has
been demonstrated in this system. The response regulator
superfamily is defined by conservation of N-terminal residues that
are involved in phosphorylation [54]. The key aspartate and lysine
residues are invariant in these phosphorylation-dependent regu-
lators. The remaining conserved residues, an acidic pair, a
VirSR Phosphotransfer
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functional roles in the coordination of the essential divalent cation
and phosphoryl group. Alignment of VirR with other response
regulators suggested that the central aspartate was D57 [7]. In this
study, the results provide evidence that D57 is highly likely to be
the site of phosphorylation, since phosphotransfer was not
observed with VirRD57N under in vitro phosphotransfer conditions
in which the wild-type VirR protein acted as a phosphoacceptor.
In addition, D57 was shown to be essential for VirR function in
vivo; when the virRD57N gene was present on the chromosome in
single copy, perfringolysin O production was not activated. The
results also indicated that other residues in the phosphorylation
pocket or elsewhere in the protein were not phosphorylated
instead of D57. It is possible that the D57N mutation caused the
misfolding of the resulting protein and the associated loss of
activity, but the observation that the mutated gene, when present
in multicopy, was able to complement the virR mutation of the
strain argues against this possibility. Unexpectedly, when the wild-
type gene was re-introduced back onto the chromosome of TS133,
the resultant VirR protein could stimulate a low level of
perfringolysin O production in the absence of VirS. This result
may be due to phosphorylation of the VirR protein by small
molecular weight phosphodonors. This phenomenon has been
observed in other two-component systems [55,56] and involves an
alternative phosphoryl moiety, such as acetyl phosphate or
carbamoyl phosphate, donating its phosphate group to a response
regulator. Phosphorylation by this process is not as efficient as that
involving the cognate sensor histidine kinase [57,58], which may
explain why perfringolysin O production was only partially
restored.
In some response regulators phosphorylation alters the protein
conformation so that steric inhibition is relieved, and consequent-
ly, dimerization and DNA binding can occur [59,60,61,62]. In
others, phosphorylation is required for interaction with RNA
polymerase [63,64,65,66]. We do not know the precise role of
phosphorylation in the VirR-dependent expression of the pfoA
gene, but previous work has shown that phosphorylation is not
essential for DNA binding [22,33]. We postulate that phosphor-
ylation is required to optimize protein-protein interactions
between VirR monomers, VirR and RNA polymerase, or both
reactions, since binding to DNA alone is not sufficient to activate
perfringolysin O production [22].
In conclusion, based on the data presented in this paper, we
propose that the regulation of perfringolysin O production in C.
perfringens is dependent on three factors. The first is the autopho-
sphorylation of VirS following the detection of an unknown signal.
This process may involve the L[T/S]6E motif. The second is a
requirement for VirS-dependent VirR phosphorylation, a process
that involves conserved motifs in both proteins. The third is the
virR gene dosage in the cell, since overexpression of wild-type and
mutated virR genes resulted in VirS-independent activation. It
appears that the VirSR system is not limited to C. perfringens, with
genes encoding orthologs of VirR and/or VirS identified in
Clostridium difficile [32], Clostridium tetani [67] and Clostridium
botulinum [68]. In addition, VirR binding sites have been identified
in C. difficile, and its VirR ortholog, RgaR, has been shown to
recognise and bind specifically to the C. perfringens VirR boxes [32].
Therefore, our studies clearly have relevance to the analysis of two
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